Novo Nordisk | NVO - Credores Comerciais

Preço das Ações
37.84
Mudança Diária
0.42 1.12%
Mensal
-2.52%
Anual
-41.53%
Q2 Previsão
35.64




Credores Comerciais Alterar Data
ANI Pharmaceuticals USD 62.58M 7.21M 2025-12
Aurora Cannabis CAD 68.03M 18.68M 2025-12
Bausch Health Companies USD 600M 16M 2025-12
Bristol-Myers Squibb USD 4.29B 1.14B 2025-09
Canopy Growth CAD 19.96M 1.83M 2025-12
Corcept Therapeutics USD 40.44M 6M 2025-12
Drreddys Laboratories INR 454.04M 854K 2025-12
Eli Lilly USD 5.38B 1.12B 2025-12
GlaxoSmithKline GBP 15.38B 294M 2025-12
Merck USD 4.15B 102M 2025-09
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Novartis USD 4.46B 99M 2025-12
Novo Nordisk DKK 19.76B 4.15B 2025-12
Novo Nordisk DKK 4.46B 15.12B 2025-06
Pacira USD 15.15M 2.54M 2025-12
Perrigo USD 474.5M 4.8M 2025-12
Phibro Animal Health USD 133.3M 2.7M 2025-12
Prestige Brands USD 42.95M 1.02M 2025-12
Sanofi EUR 22.93B 927M 2025-12
Supernus Pharmaceuticals USD 107.8M 813K 2025-12
Zoetis USD 487M 77M 2025-12